Clinical Trial Update: Carboxypeptidase-G2 in Treating Nervous System Toxic Effects in Patients Given an Overdose of Intrathecal Methotrexate [NA]

View source ↗

Summary

Clinical trial update reports completion of studies evaluating carboxypeptidase-G2 to treat nervous system toxic effects after intrathecal methotrexate overdose…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neurotoxicity
• Unspecified Adult Solid Tumor
• Unspecified Childhood Solid Tumor

Drugs mentioned

• Carboxypeptidase-G2 (glucarpidase)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Neurotoxicity, Unspecified Adult Solid Tumor, Protocol Specific | NA | Status: COMPLETED